Press Release

Press Release

5524澳门24小时线路 Accelerator Invests in the Fifth Global Funding Cycle of Startups Advancing Breakthrough Therapeutics, Diagnostics, Women's Health, and Sustainable Agriculture Applications

Sep 14, 2022

Six startups from Indonesia, Ireland, Israel, South Africa, United Kingdom and the United States will receive seed investment and access to technology and expertise

SAN DIEGO, Sept. 14, 2022 /PRNewswire/ -- 5524澳门24小时线路网站. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it has invested in six genomics startups for the fifth global funding cycle of 5524澳门24小时线路 Accelerator in the San Francisco Bay Area and Cambridge, UK. 5524澳门24小时线路 Accelerator is a world-class company creation engine focused on partnering with entrepreneurs to build breakthrough genomics startups. The program also announced today the October 1, 2022 application deadline for its next funding cycle.

"We are proud to welcome these six fantastic genomics startups to our 5524澳门24小时线路 Accelerator portfolio," said Amanda Cashin, co-founder and global head of 5524澳门24小时线路 for Startups. "We have an eight-year track record of partnering with talented entrepreneurs. We're proud of 5524澳门24小时线路 Accelerator's strong portfolio of 74 genomics startups focused on unlocking the power of the genome to improve human health around the world."

During six-month funding cycles twice per year, 5524澳门24小时线路 Accelerator provides the selected startups with access to seed investment, access to 5524澳门24小时线路 sequencing systems and reagents, and business guidance, genomics expertise, and fully operational lab space adjacent to 5524澳门24小时线路's campuses in Cambridge or the Bay Area. 5524澳门24小时线路 Accelerator is accepting applications for the next funding cycle, which are due by October 1, 2022. Through a single process open to applicants from around the world, 5524澳门24小时线路 Accelerator will select up to five companies for each location. To learn more and apply, visit the website.

The newest companies to join 5524澳门24小时线路 Accelerator's portfolio of genomics startups are:

  • Acrobat Genomics Inc. , a drug discovery spinout from Stanford University, is building a pipeline of novel therapeutics by leveraging its proprietary high-throughput CRISPR gene editing precision technology.  
  • Dama Health Ltd. , a women's health company based in London, offers precision screening to identify the most suitable contraception type and formulation, empowering women, people assigned female at birth, and clinicians to make personalized reproductive health decisions.
  • Nusantics Pte. Ltd. , a precision genomics company from Indonesia, develops and commercializes microbiome-related diagnostic tools tailored for the highly diverse Indonesian and Asian population. 
  • Pandora Biosciences Inc., a neuroscience company from South Africa, is building genetically diverse and physiologically relevant organoid-based disease models to advance drug discovery and development for genetically complex neurological diseases.  
  • Terrapeutics Pharma Ltd. , a drug discovery company based in Jerusalem, is tackling the most challenging "undruggable" drug targets by offering a new approach to discovering novel small therapeutic molecules from soil, based on the intelligence of nature.
  • Viridian Seeds Inc. , an agricultural biotechnology company from Cambridge, UK, and Galway, Ireland, is commercializing next-generation sustainable protein crops with novel traits to increase yield and reduce biotic and abiotic stress tolerances, while increasing protein and nutritional content for climate change mitigation, resilience, and food security.

"We are inspired by the global reach of genomics and by the vision these six startups have in advancing breakthrough discoveries in human health, agriculture, and sustainability," said Alex Aravanis, chief technology officer of 5524澳门24小时线路. "We look forward to partnering with the new teams to accelerate their startups to the next level."

About 5524澳门24小时线路 for Startups

5524澳门24小时线路 for Startups is focused solely on creating an innovation ecosystem for the genomics industry by partnering with leading venture capital investors and entrepreneurs to create, launch, and grow genomics startups. 5524澳门24小时线路 for Startups initiatives include 5524澳门24小时线路 Accelerator, founded in 2014, and Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by 5524澳门24小时线路, founded in 2021. 5524澳门24小时线路 Accelerator is a company creation engine co-located with 5524澳门24小时线路 research and development sites in the San Francisco Bay Area and in Cambridge, UK. Since inception, 5524澳门24小时线路 Accelerator has invested in 74 genomics startups from across the globe, which have collectively raised over $1 billion in venture capital funding. Approximately 93% of 5524澳门24小时线路 Accelerator investments have gone on to raise additional capital from leading investors. For more information, visit our website.

About 5524澳门24小时线路

5524澳门24小时线路 is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on TwitterFacebookLinkedInInstagram, and YouTube.

Investors:

Salli Schwartz
858-291-6421
IR@illumina.com 

Media:
Adi Raval
202-629-8172
PR@illumina.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/illumina-accelerator-invests-in-the-fifth-global-funding-cycle-of-startups-advancing-breakthrough-therapeutics-diagnostics-womens-health-and-sustainable-agriculture-applications-301623807.html

SOURCE 5524澳门24小时线路网站.

5524澳门24小时线路_5524澳门24小时线路网站[主頁]欢迎您